zepbound lilly - Search News

Order byBest matchMost fresh

News

Lilly, Wegovy and Zepbound

· 3d · on MSN

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. The data is the first head-to-head trial comparing the wildly popular medicines,

Continue reading

· 2d · on MSN

Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy

· 3d · on MSN

Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy

2d

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

13d

CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click ...

Zacks.com on MSN22h

Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?

Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

3d

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

5d

Zepbound Patients Fear Losing Coverage After CVS Deal for Wegovy

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results